OFIX - Orthofix International N.V.
| Previous Close | 59.10 |
| Open | 59.06 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 1400 |
| Day's Range | 57.92 - 59.28 |
| 52 Week Range | 42.68 - 61.86 |
| Volume | 73,885 |
| Avg. Volume | 159,374 |
| Market Cap | 1.096B |
| Beta | 0.22 |
| PE Ratio (TTM) | 78.09 |
| EPS (TTM) | 0.74 |
| Earnings Date | Aug 6, 2018 - Aug 10, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 66.67 |
- Business Wire•20 days ago
Orthofix Realigns Business Unit Structure, Names Brad Niemann President of Global Orthofix Spine and Davide Bianchi President of Global Orthofix Extremities
Orthofix International N.V., (OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced the realignment of its strategic business units and the promotion of Brad Niemann to President of Global Orthofix Spine, which includes the BioStim, Spine Fixation, Spinal Kinetics and Biologics businesses. The Extremity Fixation business, which will now be referred to as “Orthofix Extremities” will continue to be led globally by Davide Bianchi as the President of Global Orthofix Extremities.
- Simply Wall St.•22 days ago
Is Orthofix International NV (NASDAQ:OFIX) Expensive For A Reason? A Look At The Intrinsic Value
I am going to run you through how I calculated the intrinsic value of Orthofix International NV (NASDAQ:OFIX) by projecting its future cash flows and then discounting them to today’sRead More...
- InvestorPlace•last month
As Spinal Stocks Climb Toward Yearly Highs, There’s Still Room for Upside
Cantor Fitzgerald is starting coverage on biotech companies in the spinal segment, a market that the investment house thinks has a $9-billion global market opportunity. Globus Medical Inc (NYSE:GMED) earned an “Overweight” rating from Cantor Fitzgerald. GMED stock has a market cap of $5.41 billion and is valued at 10.6 times its book value per share.
- GlobeNewswire•last month
Factors of Influence in 2018, Key Indicators and Opportunity within Southern Missouri, Marlin Business Services, Golden Ocean Group, Orthofix International N.V, Greenlight Capital Re, and ServiceSource International — New Research Emphasizes Economic Growth
NEW YORK, June 05, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Southern ...
- Benzinga•last month
Cantor Fitzgerald Taps Spinal Stocks: 4 Top Picks
Spine stocks were steadied with supportive coverage from the Street this week. The Ratings Cantor Fitzgerald analysts Craig Bijou and Jordan Abrams initiated coverage on: Globus Medical Inc (NYSE: GMED ...
- Zacks•last month
New Strong Sell Stocks for June 1st
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
- Business Wire•2 months ago
Orthofix to Present at Jefferies 2018 Global Healthcare Conference
Orthofix International N.V. , a global medical device company focused on musculoskeletal healing products and value-added services, today announced that President and Chief Executive Officer Brad Mason will present at the Jefferies 2018 Global Healthcare Conference in New York City on Tuesday, June 5, 2018 at 3:30 p.m.
- Zacks•2 months ago
Orthofix (OFIX) Stock Declines 13% on '18 Earnings View Cut
Despite the bottom line of Orthofix (OFIX) betters estimates, the company's shares drop due to trimmed 2018 earnings outlook.
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of OFIX earnings conference call or presentation 30-Apr-18 8:30pm GMT
Q1 2018 Orthofix International NV Earnings Call
- Associated Press•2 months ago
Orthofix: 1Q Earnings Snapshot
On a per-share basis, the Willemstad, Netherlands Antilles-based company said it had net income of 27 cents. Earnings, adjusted for non-recurring costs and to account for discontinued operations, came ...
- Business Wire•2 months ago
Orthofix Reports First Quarter 2018 Financial Results
Orthofix International N.V. today reported its financial results for the first quarter ended March 31, 2018. Net sales were $108.7 million, diluted earnings per share from continuing operations was $0.27 and adjusted earnings per share from continuing operations was $0.39.
- ACCESSWIRE•2 months ago
Orthofix International NV to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / April 30, 2018 / Orthofix International NV (NASDAQ: OFIX ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 30, 2018 at 4:30 PM Eastern ...
- Business Wire•3 months ago
Orthofix Schedules First Quarter 2018 Earnings Release and Conference Call for April 30, 2018
Orthofix International N.V. (OFIX), a global medical device company focused on musculoskeletal healing products and value-added services, today announced that it plans to release financial results for the first quarter 2018 after market close on Monday, April 30, 2018. Brad Mason, Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 4:30 p.m. ET the same day. Interested parties may access the conference call by dialing (844) 809-1992 in the U.S. and (612) 979-9886 outside the U.S., and referencing the conference ID 5288605.
- Zacks•4 months ago
3D Printing in Vogue: 4 MedTech Stocks to Keep an Eye On
3D printing lends a competitive edge to medical device manufacturers by enhancing efficiency and cutting down on processing time.
- ACCESSWIRE•4 months ago
Blog Exposure - FDA Cleared Orthofix International’s G-Beam Fusion Beaming System
Stock Monitor: AcelRx Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 26, 2018 / Active-Investors.com has just released a free research report on Orthofix International N.V. (NASDAQ: OFIX ...
- Zacks•4 months ago
FDA Nod for Orthofix's G-Beam to Boost Extremity Fixation SBU
Orthofix's (OFIX) latest receipt of FDA approval expected to enhance the Extremity Fixation portfolio.
- Business Wire•4 months ago
Orthofix Receives FDA 510(k) Clearance of G-Beam Fusion Beaming System
Orthofix International N.V., , a global medical device company focused on musculoskeletal healing products and value added services, announced the U.S. Food and Drug Administration 510 clearance for its new internal fixation system, the G-Beam™ Fusion Beaming System.
- Zacks•4 months ago
What's Driving Orthofix International to a New 52-Week High
Orthofix International is (OFIX) strong on recent buyouts as well as the FDA approval.
- Zacks•4 months ago
Orthopedic Device Market Gains Momentum: 3 Stocks in Focus
The orthopedics market holds immense potential for investors who are keen on the healthcare space for long-term gains.
- Zacks•4 months ago
Orthofix to Buy Spinal Kinetics, Widens Spine Fixation Suite
Orthofix's (OFIX) latest deal to boost Spine Fixation portfolio and strengthen hold in the high-potential artificial disc market buoys optimism.
- Business Wire•4 months ago
Orthofix Announces Agreement to Acquire Spinal Kinetics
Orthofix International N.V. , a global medical device company focused on musculoskeletal healing products and value-added services, today announced that it has entered into a definitive agreement to acquire Spinal Kinetics Inc., a privately held developer and manufacturer of artificial cervical and lumbar discs.
- Business Wire•4 months ago
Orthofix Announces Appointment of John Sicard to Board of Directors
Orthofix International N.V., , a global medical device company focused on musculoskeletal healing products and value-added services, today announced that John Sicard has been named to its Board of Directors.
